- Capacity expansion and upgradation of manufacturing facilities
|
- Establishment of a new R&D Centre
|
- Repayment / prepayment of certain outstanding borrowings
|
- Working capital requirements
|
- Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia)
|
- General corporate purposes
|